Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Update

Sensus Healthcare, Inc. (NASDAQ:SRTS) saw a large decline in short interest in the month of March. As of March 31st, there was short interest totalling 33,400 shares, a decline of 49.2% from the March 15th total of 65,800 shares. Based on an average trading volume of 162,000 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.3% of the shares of the company are sold short.

Institutional Trading of Sensus Healthcare

A number of institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. lifted its position in shares of Sensus Healthcare by 24.3% during the 1st quarter. Vanguard Group Inc. now owns 596,224 shares of the company’s stock valued at $6,034,000 after acquiring an additional 116,409 shares during the period. Renaissance Technologies LLC lifted its position in shares of Sensus Healthcare by 33.2% during the 2nd quarter. Renaissance Technologies LLC now owns 367,934 shares of the company’s stock valued at $1,159,000 after acquiring an additional 91,800 shares during the period. Millennium Management LLC lifted its position in shares of Sensus Healthcare by 150.7% during the 2nd quarter. Millennium Management LLC now owns 207,715 shares of the company’s stock valued at $1,595,000 after acquiring an additional 124,863 shares during the period. Geode Capital Management LLC lifted its position in shares of Sensus Healthcare by 7.9% during the 1st quarter. Geode Capital Management LLC now owns 132,601 shares of the company’s stock valued at $691,000 after acquiring an additional 9,684 shares during the period. Finally, Dimensional Fund Advisors LP lifted its position in shares of Sensus Healthcare by 92.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 131,453 shares of the company’s stock valued at $1,330,000 after acquiring an additional 63,155 shares during the period. 25.30% of the stock is currently owned by institutional investors.

Sensus Healthcare Trading Down 2.9 %

Shares of NASDAQ SRTS opened at $3.35 on Thursday. Sensus Healthcare has a 12 month low of $1.79 and a 12 month high of $5.38. The stock has a 50 day moving average of $3.92 and a 200-day moving average of $3.00. The company has a market capitalization of $54.92 million, a P/E ratio of 111.67 and a beta of 0.91.

Sensus Healthcare (NASDAQ:SRTS) last issued its earnings results on Thursday, February 8th. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.12 by $0.14. The company had revenue of $12.57 million during the quarter, compared to the consensus estimate of $12.10 million. Sensus Healthcare had a return on equity of 1.04% and a net margin of 1.99%. Analysts predict that Sensus Healthcare will post 0.08 EPS for the current fiscal year.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.